Studies on the Australia-SH antigen in Norway.
D000741:Anemia, Aplastic / Q000276:immunology; D001782:Blood Donors; D001803:Blood Transfusion; D002353:Carrier State / Q000453:epidemiology* / Q000276:immunology; D056486:Chemical and Drug Induced Liver Injury / Q000276:immunology; D002779:Cholestasis / Q000276:immunology; D003168:Complement Fixation Tests; D006386:Hemagglutination Tests; D006402:Hematologic Diseases / Q000276:immunology; D006467:Hemophilia A / Q000276:immunology; D006506:Hepatitis A / Q000276:immunology; D006509:Hepatitis B / Q000276:immunology* / Q000517:prevention & control; D006511:Hepatitis B Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000276:immunology*; D007106:Immune Sera; D005779:Immunodiffusion; D008854:Microscopy, Electron; D009664:Norway; D055728:Primary Myelofibrosis / Q000276:immunology; D005719:gamma-Globulins
D006511:Hepatitis B Antigens; D007106:Immune Sera; D005719:gamma-Globulins